MX2023003983A - Procedimiento para racemizar y aislar atropisomeros de 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d] pirimidin-2,4(1h,3h)-diona. - Google Patents
Procedimiento para racemizar y aislar atropisomeros de 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d] pirimidin-2,4(1h,3h)-diona.Info
- Publication number
- MX2023003983A MX2023003983A MX2023003983A MX2023003983A MX2023003983A MX 2023003983 A MX2023003983 A MX 2023003983A MX 2023003983 A MX2023003983 A MX 2023003983A MX 2023003983 A MX2023003983 A MX 2023003983A MX 2023003983 A MX2023003983 A MX 2023003983A
- Authority
- MX
- Mexico
- Prior art keywords
- isolating
- racemizing
- atropisomers
- methylpyridin
- pyrido
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000008569 process Effects 0.000 title abstract 4
- UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 title 1
- 229940126062 Compound A Drugs 0.000 abstract 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 3
- 229940095064 tartrate Drugs 0.000 abstract 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B55/00—Racemisation; Complete or partial inversion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Se proporciona en el presente documento un procedimiento que comprende calentar una composición que comprende el (P)-compuesto A o una sal del mismo y un disolvente hasta una temperatura de 250ºC a 350ºC para formar el compuesto A racemizado. También se proporciona un procedimiento para aislar el (P)-compuesto A de una composición que comprende el (P)-compuesto A y un tartrato, tal como se describe en el presente documento. Se proporciona además en el presente documento, un procedimiento para aislar un ácido libre de un tartrato o a hidrato del mismo de una composición que comprende un tartrato, (P)-compuesto A, y un disolvente orgánico.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063088848P | 2020-10-07 | 2020-10-07 | |
| US202163162278P | 2021-03-17 | 2021-03-17 | |
| PCT/US2021/053859 WO2022076623A1 (en) | 2020-10-07 | 2021-10-06 | Process for racemizing and isolating atropisomers of 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023003983A true MX2023003983A (es) | 2023-04-24 |
Family
ID=78500740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023003983A MX2023003983A (es) | 2020-10-07 | 2021-10-06 | Procedimiento para racemizar y aislar atropisomeros de 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d] pirimidin-2,4(1h,3h)-diona. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230391771A1 (es) |
| EP (1) | EP4225755A1 (es) |
| JP (1) | JP2023544775A (es) |
| KR (1) | KR20230083318A (es) |
| CN (1) | CN116323611A (es) |
| AU (1) | AU2021357815A1 (es) |
| CA (1) | CA3196612A1 (es) |
| CL (1) | CL2023000992A1 (es) |
| IL (1) | IL301517A (es) |
| MX (1) | MX2023003983A (es) |
| TW (1) | TW202229276A (es) |
| WO (1) | WO2022076623A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4341260A1 (en) | 2021-05-19 | 2024-03-27 | Teva Pharmaceuticals International GmbH | Process for preparation of sotorasib and solid state form thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2382074A (en) * | 2001-11-14 | 2003-05-21 | Basf Ag | Recovery of chiral tartaric acid resolving agents |
| JOP20190272A1 (ar) | 2017-05-22 | 2019-11-21 | Amgen Inc | مثبطات kras g12c وطرق لاستخدامها |
| JP2020090482A (ja) * | 2018-11-16 | 2020-06-11 | アムジエン・インコーポレーテツド | Ｋｒａｓ ｇ１２ｃ阻害剤化合物の重要な中間体の改良合成法 |
-
2021
- 2021-10-06 AU AU2021357815A patent/AU2021357815A1/en active Pending
- 2021-10-06 CA CA3196612A patent/CA3196612A1/en active Pending
- 2021-10-06 MX MX2023003983A patent/MX2023003983A/es unknown
- 2021-10-06 US US18/030,685 patent/US20230391771A1/en active Pending
- 2021-10-06 CN CN202180068032.3A patent/CN116323611A/zh active Pending
- 2021-10-06 EP EP21802088.1A patent/EP4225755A1/en active Pending
- 2021-10-06 IL IL301517A patent/IL301517A/en unknown
- 2021-10-06 WO PCT/US2021/053859 patent/WO2022076623A1/en active Application Filing
- 2021-10-06 KR KR1020237015187A patent/KR20230083318A/ko unknown
- 2021-10-06 JP JP2023520495A patent/JP2023544775A/ja active Pending
- 2021-10-07 TW TW110137330A patent/TW202229276A/zh unknown
-
2023
- 2023-04-05 CL CL2023000992A patent/CL2023000992A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2023000992A1 (es) | 2023-09-15 |
| IL301517A (en) | 2023-05-01 |
| TW202229276A (zh) | 2022-08-01 |
| EP4225755A1 (en) | 2023-08-16 |
| US20230391771A1 (en) | 2023-12-07 |
| KR20230083318A (ko) | 2023-06-09 |
| WO2022076623A1 (en) | 2022-04-14 |
| CN116323611A (zh) | 2023-06-23 |
| AU2021357815A1 (en) | 2023-04-20 |
| CA3196612A1 (en) | 2022-04-14 |
| JP2023544775A (ja) | 2023-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023237060A1 (en) | TYK2 inhibitors and uses thereof | |
| EP3592746B1 (en) | Tyk2 inhibitors, uses, and methods for production thereof | |
| EP3262049B1 (en) | Tyk2 inhibitors and uses thereof | |
| KR101609412B1 (ko) | 아자 2 고리형 화합물 또는 그 염 | |
| ES2702659T3 (es) | Derivado de tetrahidrociclopentapirrol y un método para prepararlo | |
| EP3914357A1 (en) | Tyk2 inhibitors and uses thereof | |
| WO2014011902A1 (en) | Irak inhibitors and uses thereof | |
| EP1937690A1 (en) | Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
| WO2014011911A2 (en) | Irak inhibitors and uses thereof | |
| NZ538156A (en) | Use of and some novel imidazopyridines | |
| EA020588B1 (ru) | ТИЕНО[2,3-b]ПИРИДИНДИОНОВЫЕ АКТИВАТОРЫ АМФК И ИХ ТЕРАПЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ | |
| WO2014194201A2 (en) | Cdk8 inhibitors and uses thereof | |
| MX2023003983A (es) | Procedimiento para racemizar y aislar atropisomeros de 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d] pirimidin-2,4(1h,3h)-diona. | |
| KR101794321B1 (ko) | 바이사이클릭 그룹 치환된 피리미딘 화합물 | |
| WO2014194242A2 (en) | Flt3 inhibitors and uses thereof | |
| JP2022540063A (ja) | ヒドラゾンアミド誘導体及びその抗骨粗鬆症薬の調製における応用 | |
| MX2021000683A (es) | Derivados de imidazo[1,2-b]piridazina como inhibidores de trk. | |
| WO2022052924A1 (zh) | 一类含氮稠环类化合物的制备方法和用途 | |
| EP3954680A1 (en) | Piperazine amide derivative, preparation method therefor, and use thereof in medicine | |
| WO2015158313A1 (en) | Sulfonamide derivatives and pharmaceutical applications thereof | |
| CA2596667A1 (en) | Process of synthesizing tadalafil | |
| AR123718A1 (es) | Procedimiento para racemizar y aislar atropisómeros de 7-cloro-6-fluoro-1-(2-isopropil-4-metilpiridin-3-il)pirido[2,3-d]pirimidin-2,4(1h,3h)-diona | |
| FI91758C (fi) | Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi | |
| FI63401C (fi) | Nytt foerfarande foer framstaellning av 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-karboxylsyra- och 1-oxo-1h-pyrimido(1,2-a)kinolin-2-karboxylsyraderivat | |
| WO2014082738A1 (en) | Heteroquinoline-3-carboxamides as kcnq2/3 modulators |